|
DAGLA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.115890E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.31199999999921E-05 |
| Normal-vs-Stage2 |
2.801500E-03 |
| Normal-vs-Stage3 |
1.350630E-01 |
| Normal-vs-Stage4 |
2.383600E-01 |
| Stage1-vs-Stage2 |
9.916800E-01 |
| Stage1-vs-Stage3 |
4.278100E-02 |
| Stage1-vs-Stage4 |
2.520400E-01 |
| Stage2-vs-Stage3 |
1.159190E-01 |
| Stage2-vs-Stage4 |
3.059400E-01 |
| Stage3-vs-Stage4 |
8.925600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.788500E-04 |
| Normal-vs-AfricanAmerican |
8.345500E-02 |
| Normal-vs-Asian |
2.029400E-01 |
| Caucasian-vs-AfricanAmerican |
5.717700E-02 |
| Caucasian-vs-Asian |
6.747200E-01 |
| AfricanAmerican-vs-Asian |
8.124400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.02819999999871E-05 |
| Normal-vs-Female |
1.791620E-01 |
| Male-vs-Female |
8.382500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.849400E-04 |
| Normal-vs-Extreme_Weight |
2.6527999996695E-07 |
| Normal-vs-Obese |
2.996200E-02 |
| Normal-vs-Extreme_Obese |
6.932600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.815400E-01 |
| Normal_Weight-vs-Obese |
2.659800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.785700E-02 |
| Extreme_Weight-vs-Obese |
1.985850E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.127800E-02 |
| Obese-vs-Extreme_Obese |
3.296000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.572800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.415100E-03 |
| Normal-vs-Age(61-80Yrs) |
2.03330000003721E-06 |
| Normal-vs-Age(81-100Yrs) |
1.779700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.787000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.532300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.174020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.365930E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.318000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.150400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.14069999998823E-06 |
| Normal-VS-Type2 PRCC |
3.056900E-03 |
| Normal-VS-KIRP CIMP |
8.355000E-01 |
| Normal-VS-Unclassified PRCC |
7.238200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.518800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.272360E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.917700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.137040E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.010760E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.457200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.121660E-02 |
| Normal-vs-N1 |
6.584400E-01 |
| Normal-vs-N2 |
6.120200E-02 |
| N0-vs-N1 |
8.323800E-02 |
| N0-vs-N2 |
6.811000E-01 |
| N1-vs-N2 |
2.111400E-01 |
|
|
